Skip to main content
. 2022 Feb 22;40(15):2324–2330. doi: 10.1016/j.vaccine.2022.02.064

Table 1.

Distribution of Covid vaccines in the Gerocovid Vax Study population (n = 3004).

N (%) M/F Age men yrs (mean (SD)) Age women yrs (mean (SD))
BNT162b2
(BioNTech-Pfizer)
2796 (92.8) 866/2138 79 (9) 85 (9)
mRNA-1273
(Moderna)
207 (7.2) 55/152 80 (9) 86 (8)
ChAdOx1/nCoV-19
(Vaxrevia)
1 (0) 1/0 73
Race
 White 2940 (97.9) 849/2091
 Black 18 (0.6) 1/17
 Asian 4 (0.1) 2/2
 Other/unknown 42 (1.4) 14/28